Article Link: FDA Approves Tremfya (guselkumab) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis ...
FDA Expands Indication for Soliqua 100/33 (insulin glargine and lixisenatide injection) to Include Type 2 Diabetes Patients Uncontrolled on Oral Antidiabetic Medicines
Article Link: FDA Expands Indication for Soliqua 100/33 (insulin glargine and lixisenatide injection) to Include Type 2 Diabetes Patients Uncontrolled...
FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push
Article Link: FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push SAN DIEGO, Feb. 26, 2019 /...
FDA Approves Gloperba (colchicine) for Prophylaxis of Adult Gout Flares
Article Link: FDA Approves Gloperba (colchicine) for Prophylaxis of Adult Gout Flares WOBURN, Mass.–(BUSINESS WIRE)–February ...
FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Article Link: FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (...
FDA Approves Esperoct (turoctocog alfa pegol, N8-GP) for Hemophilia A
Article Link: FDA Approves Esperoct (turoctocog alfa pegol, N8-GP) for Hemophilia A Bagsværd, Denmark, 19 February 2019 – Novo Nord...
FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection
Article Link: FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following C...
FDA Approves Egaten (triclabendazole) for the Treatment of Fascioliasis, a Neglected Tropical Disease
Article Link: FDA Approves Egaten (triclabendazole) for the Treatment of Fascioliasis, a Neglected Tropical Disease Basel, Switzerland, F...
FDA Approves Darzalex (daratumumab) Split-Dosing Regimen
Article Link: FDA Approves Darzalex (daratumumab) Split-Dosing Regimen Horsham, PA, February 12, 2019 – The Janssen Pharmaceutical Compan...
FDA Approves Cablivi (caplacizumab-yhdp) for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults
Article Link: FDA Approves Cablivi (caplacizumab-yhdp) for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults February 6, 2019...
